CoChat

The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities

Open access
Stewart, Elizabeth, Federico, Sara, Karlstrom, Asa, Shelat, Anang, Sablauer, Andras, Pappo, Alberto, Dyer, Michael A. · 2016 · Developmental Biology
Cited by 79

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Significant advances have been made over the past 25 years in our understanding of the most common adult solid tumors such as breast, colon, lung and prostate cancer. Much less is known about childhood solid tumors because they are rare and because they originate in developing organs during fetal development, childhood and adolescence. It can be very difficult to study the cellular origins of pediatric solid tumors in developing organs characterized by rapid proliferative expansion, growth factor signaling, developmental angiogenesis, programmed cell death, tissue reorganization and cell migration. Not only has the etiology of pediatric cancer remained elusive because of their developmental origins, but it also makes it more difficult to treat. Molecular targeted therapeutics that alter developmental pathway signaling may have devastating effects on normal organ development. Therefore, basic research focused on the mechanisms of development provides an essential foundation for pediatric solid tumor translational research. In this article, we describe new resources available for the developmental biology and oncology research communities. In a companion paper, we present the detailed characterization of an orthotopic xenograft of a pediatric solid tumor derived from sympathoadrenal lineage during development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ydbio.2015.03.001

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 54

  1. Abramson, 1979, Second tumors in nonirradiated bilateral retinoblastoma, Am. J. Ophthalmol., 87, 624, 10.1016/0002-9394(79)90293-9 · DOI
  2. Applebaum, 2011, Clinical features and outcomes in patients with extraskeletal Ewing sarcoma, Cancer, 117, 3027, 10.1002/cncr.25840 · doi:10.1002/cncr.25840
  3. Barr, 1997, Chromosomal translocations involving paired box transcription factors in human cancer, Int. J. Biochem. Cell Biol., 29, 1449, 10.1016/S1357-2725(97)00095-2 · DOI
  4. Benavente, 2013, Cross-species genomic and epigenomic landscape of retinoblastoma, Oncotarget, 4, 844, 10.18632/oncotarget.1051 · DOI
  5. Brodeur, 2003, Neuroblastoma: biological insights into a clinical enigma, Nat. Rev. Cancer, 3, 203, 10.1038/nrc1014 · DOI · Paper page
  6. Cepko, 1996, Cell fate determination in the vertebrate retina, Proc. Natl. Acad. Sci. USA, 93, 589, 10.1073/pnas.93.2.589 · DOI · Paper page
  7. Chen, 2013, Targeting oxidative stress in embryonal rhabdomyosarcoma, Cancer Cell, 24, 710, 10.1016/j.ccr.2013.11.002 · DOI · Paper page
  8. Chen, 2015, Pediatric solid tumor genomics and developmental pliancy, Oncogene, 10.1038/onc.2014.474 · DOI
  9. Chen, 2008, Oncogenic mutations of ALK kinase in neuroblastoma, Nature, 455, 971, 10.1038/nature07399 · DOI · Paper page
  10. Cheung, 2012, Association of age at diagnosis and genetic mutations in patients with neuroblastoma, J. Am. Med. Assoc., 307, 1062, 10.1001/jama.2012.228 · DOI · Paper page
  11. Cheung, 2013, Neuroblastoma: developmental biology, cancer genomics and immunotherapy, Nat. Rev. Cancer, 13, 397, 10.1038/nrc3526 · DOI · Paper page
  12. Chow, 1971, Receptive field characteristics of striate cortical neurons in the rabbit, Brain Res., 33, 337, 10.1016/0006-8993(71)90107-7 · DOI
  13. Downing, 2012, The pediatric cancer genome project, Nat. Genet., 44, 619, 10.1038/ng.2287 · DOI · Paper page
  14. Dyer, M., 2015. In: Chalupa, L., Williams R., (Eds.), Eye, Retina, and Visual System of the Mouse, MIT Press, in press
  15. Finegold, 2007, Protocol for the examination of specimens from pediatric patients with hepatoblastoma, Arch. Pathol. Lab. Med., 131, 520, 10.5858/2007-131-520-PFTEOS · doi:10.5858/2007-131-520-pfteos
  16. Hatley, 2012, A mouse model of rhabdomyosarcoma originating from the adipocyte lineage, Cancer Cell, 22, 536, 10.1016/j.ccr.2012.09.004 · DOI
  17. Hicks, 2007, Clinicopathologic features of osteosarcoma in patients with Rothmund–Thomson syndrome, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 25, 370, 10.1200/JCO.2006.08.4558 · DOI
  18. Johnson, 2007, Neuronal differentiation and synaptogenesis in retinoblastoma, Cancer Res., 67, 2701, 10.1158/0008-5472.CAN-06-3754 · DOI
  19. Lessnick, 2012, Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets, Annu. Rev. Pathol., 7, 145, 10.1146/annurev-pathol-011110-130237 · DOI · Paper page
  20. London, 2005, Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 23, 6459, 10.1200/JCO.2005.05.571 · DOI · Paper page
  21. Lopez-Terrada, 2009, Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors, Hum. Pathol., 40, 783, 10.1016/j.humpath.2008.07.022 · DOI · Paper page
  22. Lu, 2015, The genomic landscape of childhood and adolescent melanoma, J. Investig. Dermatol., 10.1038/jid.2014.425 · DOI · Paper page
  23. Macpherson, 2007, Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy, Cancer Res., 67, 7547, 10.1158/0008-5472.CAN-07-0276 · DOI
  24. McEvoy, 2011, Coexpression of normally incompatible developmental pathways in retinoblastoma genesis, Cancer Cell, 20, 260, 10.1016/j.ccr.2011.07.005 · DOI
  25. McEvoy, 2015, RB1 inactivation by chromothripsis in human retinoblastoma, Oncotarget
  26. McIntyre, 1994, Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 12, 925, 10.1200/JCO.1994.12.5.925 · DOI · Paper page
  27. Meyers, 1993, Osteogenic sarcoma with clinically detectable metastasis at initial presentation, J. Clin. Oncol., 11, 449, 10.1200/JCO.1993.11.3.449 · DOI · Paper page
  28. Miller, 1990, Frequency and structure of p53 rearrangements in human osteosarcoma, Cancer Res., 50, 7950
  29. Missiaglia, 2012, PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification, J. Clin. Oncol., 30, 1670, 10.1200/JCO.2011.38.5591 · DOI · Paper page
  30. Molenaar, 2012, LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression, Nat. Genet., 44, 1199, 10.1038/ng.2436 · DOI · Paper page
  31. Mosse, 2004, Germline PHOX2B mutation in hereditary neuroblastoma, Am. J. Hum. Genet., 75, 727, 10.1086/424530 · DOI · Paper page
  32. Mosse, 2014, Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project, Pediatr. Blood Cancer, 61, 627, 10.1002/pbc.24777 · DOI
  33. Newton, 1988, Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 6, 67, 10.1200/JCO.1988.6.1.67 · DOI · Paper page
  34. Ognjanovic, 2009, Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005, Cancer, 115, 4218, 10.1002/cncr.24465 · DOI · Paper page
  35. Pappo, 2003, Melanoma in children and adolescents, Eur. J. Cancer, 39, 2651, 10.1016/j.ejca.2003.06.001 · DOI · Paper page
  36. Perilongo, 1999, Liver tumours, Eur. J. Cancer, 35, 953, 10.1016/S0959-8049(99)00049-0 · DOI
  37. Raabe, 2008, Prevalence and functional consequence of PHOX2B mutations in neuroblastoma, Oncogene, 27, 469, 10.1038/sj.onc.1210659 · DOI
  38. Raney, 2001, Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V, J. Pediatr. Hematol. Oncol., 23, 215, 10.1097/00043426-200105000-00008 · DOI · Paper page
  39. Sausen, 2013, Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma, Nat. Genet., 45, 12, 10.1038/ng.2493 · DOI · Paper page
  40. Schulte, 2012, MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells, Oncogene, 32, 1059, 10.1038/onc.2012.106 · DOI
  41. Scrable, 1989, A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting, Proc. Natl. Acad. Sci. USA, 86, 7480, 10.1073/pnas.86.19.7480 · DOI · Paper page
  42. Sherr, 2001, The INK4a/ARF network in tumour suppression, Nat. Rev. Mol. Cell Biol., 2, 731, 10.1038/35096061 · DOI · Paper page
  43. Spector, 2012, The epidemiology of hepatoblastoma, Pediatr. Blood Cancer, 59, 776, 10.1002/pbc.24215 · DOI · Paper page
  44. Stahl, 2011, Risk of recurrence and survival after relapse in patients with Ewing sarcoma, Pediatr. Blood Cancer, 57, 549, 10.1002/pbc.23040 · DOI · Paper page
  45. Strouse, 2005, Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database, J. Clin. Oncol., 23, 4735, 10.1200/JCO.2005.02.899 · DOI · Paper page
  46. Tirode, 2015, Co-association between STAG2 and TP53 mutations defines an aggressive subgroup of Ewing Sarcoma, Cancer Discov.
  47. Trochet, 2005, PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome, Am. J. Hum. Genet., 76, 421, 10.1086/428366 · DOI · Paper page
  48. Walkley, 2008, Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease, Genes Dev., 22, 1662, 10.1101/gad.1656808 · DOI · Paper page
  49. Weiss, 1997, Targeted expression of MYCN causes neuroblastoma in transgenic mice, EMBO J., 16, 2985, 10.1093/emboj/16.11.2985 · DOI · Paper page
  50. Whiteman, 1997, Risk factors for childhood melanoma in Queensland, Australia, Int. J. Cancer, 70, 26, 10.1002/(SICI)1097-0215(19970106)70:1<26::AID-IJC4>3.0.CO;2-8 · DOI · Paper page
  51. Williamson, 2010, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, J. Clin. Oncol., 28, 2151, 10.1200/JCO.2009.26.3814 · DOI · Paper page
  52. Wong, 2013, Incidence of childhood and adolescent melanoma in the United States: 1973-2009, Pediatrics, 131, 846, 10.1542/peds.2012-2520 · DOI · Paper page
  53. Zhang, 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, 481, 329, 10.1038/nature10733 · DOI · Paper page
  54. Zhu, 2012, Activated ALK collaborates with MYCN in neuroblastoma pathogenesis, Cancer Cell, 21, 362, 10.1016/j.ccr.2012.02.010 · DOI · Paper page

Cited by

See all 79

Metadata

Authors
Stewart, E., Federico, S., Karlstrom, A., Shelat, A., Sablauer, A., Pappo, A., & Dyer, M. A.
Venue
Developmental Biology
Publisher
Elsevier BV
Published
2016-03
Volume
411
Issue
2
Pages
287-293
ISSN
0012-1606 (ISSN-L)
OpenAlex
W2030873686
Cited by
79
References
7
FWCI
3.09
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • NCI (CA21765)
  • NIH (EY014867, EY018599, CA168875)
  • the American Lebanese Syrian Associated Charities (ALSAC)
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • HHMI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. https://app.cochat.ai/papers/10.1016/j.ydbio.2015.03.001
The paper
Stewart, E., Federico, S., Karlstrom, A., Shelat, A., Sablauer, A., Pappo, A., & Dyer, M. A. (2016). The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Developmental Biology. https://doi.org/10.1016/j.ydbio.2015.03.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.